EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hybrid PET / MRI Imaging of 18F ‐Fluorodeoxyglucose and 18‐ kDa Translocator Protein for Presurgical Localization in Refractory Epilepsy

Siqi Zhang iD, Jie Hu iD, Zhigang Qi, Chenyang Yao, Bixiao Cui, Jingjuan Wang, Zhenming Wang, Jie Lu iD

CNS Neuroscience & Therapeutics · 2025

DOI: 10.1111/cns.70251 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Siqi Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, Xuanwu Hospital Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Fluorodeoxyglucose F18, Magnetic Resonance Imaging, Positron-Emission Tomography. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Surgery remains the only curative option for a third of refractory epilepsy patients, though success depends on precise localization of the epileptogenic zone (EZ). This study aims to assess the clinical value of hybrid 18 F‐FDG and 18 F‐DPA‐714 PET/MRI for accurate localization and precise boundary delineation.

Methods

The refractory epilepsy patients who underwent surgery at Xuanwu Hospital from November 2022 to November 2023 were retrospectively recruited. Preoperative simultaneous 18 F‐FDG and 18 F‐DPA‐714 PET/MRI imaging were analyzed using the asymmetry index (AI) and a 4‐point visual score, with the surgical site and pathological findings serving as the gold standard.

Results

A total of 43 patients (mean age: 26.30 ± 8.37 years, male: 28) were included in this study. Lesion localization accuracy within the EZ was 76.7% for 18 F‐FDG PET/MRI, 69.8% for 18 F‐DPA‐714 PET/MRI, and 60.5% for conventional MRI ( p = 0.26). In 26 MRI‐positive cases, conventional MRI accurately localized all lesions within the EZ, with three cases showing negative findings on 18 F‐FDG images and six on 18 F‐DPA‐714. Among 17 MRI‐negative patients, thirteen demonstrated positive results on hybrid PET/MRI. Additionally, 18 F‐DPA‐714 PET/MRI proved more effective in delineating lesion boundaries. Compared to 18 F‐FDG, the AI score was significantly lower (0.25 ± 0.18 vs. 0.46 ± 0.19, p < 0.001), while the visual score was higher (4.00 ± 2.00 vs. 3.00 ± 0.00, p = 0.01).

Conclusion

18 F‐DPA‐714 PET/MRI can effectively complement conventional MRI in the preoperative assessment of refractory epilepsy, with localization accuracy on par with 18 F‐FDG and enhanced capability in delineating lesion boundaries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistant EpilepsyFluorodeoxyglucose F18Magnetic Resonance ImagingPositron-Emission TomographyReceptors, GABAHumansMaleFemaleAdultYoung AdultRetrospective StudiesAdolescentRadiopharmaceuticalsMultimodal ImagingPreoperative Care

Stichwörter der Autor:innen

PET/MRIfluorodeoxyglucoserefractory epilepsytranslocator protein 18 kDa

Substanzen

Fluorodeoxyglucose F18RadiopharmaceuticalsTSPO protein, humanReceptors, GABA

Autor:innen und Institutionen

  • Department of Radiology and Nuclear Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
  • Department of Radiation Oncology, Xuanwu Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Siqi Zhang, Jie Hu, Jie Lu

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Zhang, S., Hu, J., Qi, Z., Yao, C., Cui, B., Wang, J., Wang, Z., & Lu, J. (2025). Hybrid PET / MRI Imaging of 18F ‐Fluorodeoxyglucose and 18‐ kDa Translocator Protein for Presurgical Localization in Refractory Epilepsy. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70251

Vancouver

Zhang S, Hu J, Qi Z, Yao C, Cui B, Wang J, et al. Hybrid PET / MRI Imaging of 18F ‐Fluorodeoxyglucose and 18‐ kDa Translocator Protein for Presurgical Localization in Refractory Epilepsy. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70251

BibTeX
@article{Zhang2025,
  author = {Zhang, Siqi and Hu, Jie and Qi, Zhigang and Yao, Chenyang and Cui, Bixiao and Wang, Jingjuan and Wang, Zhenming and Lu, Jie},
  title = {Hybrid PET / MRI Imaging of 18F ‐Fluorodeoxyglucose and 18‐ kDa Translocator Protein for Presurgical Localization in Refractory Epilepsy},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2025},
  doi = {10.1111/cns.70251}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche